BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 29482060)

  • 21. Activation of Class I histone deacetylases contributes to mitochondrial dysfunction in cardiomyocytes with altered complex activities.
    Lkhagva B; Kao YH; Lee TI; Lee TW; Cheng WL; Chen YJ
    Epigenetics; 2018; 13(4):376-385. PubMed ID: 29613828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs.
    Wang Y; Wallach J; Duane S; Wang Y; Wu J; Wang J; Adejare A; Ma H
    Drug Des Devel Ther; 2017; 11():1369-1382. PubMed ID: 28496307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells.
    Choi SY; Kee HJ; Kurz T; Hansen FK; Ryu Y; Kim GR; Lin MQ; Jin L; Piao ZH; Jeong MH
    J Cell Mol Med; 2016 Dec; 20(12):2289-2298. PubMed ID: 27420561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of Class IIa HDACs improves endothelial barrier function in endotoxin-induced acute lung injury.
    Kovacs-Kasa A; Kovacs L; Cherian-Shaw M; Patel V; Meadows ML; Fulton DJ; Su Y; Verin AD
    J Cell Physiol; 2021 Apr; 236(4):2893-2905. PubMed ID: 32959895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel isoform-selective inhibitors within class I histone deacetylases.
    Hu E; Dul E; Sung CM; Chen Z; Kirkpatrick R; Zhang GF; Johanson K; Liu R; Lago A; Hofmann G; Macarron R; de los Frailes M; Perez P; Krawiec J; Winkler J; Jaye M
    J Pharmacol Exp Ther; 2003 Nov; 307(2):720-8. PubMed ID: 12975486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of sulforaphane on histone deacetylase activity in keratinocytes: Differences between in vitro and in vivo analyses.
    Dickinson SE; Rusche JJ; Bec SL; Horn DJ; Janda J; Rim SH; Smith CL; Bowden GT
    Mol Carcinog; 2015 Nov; 54(11):1513-20. PubMed ID: 25307283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone deacetylase and GATA-binding factor 6 regulate arterial remodeling in angiotensin II-induced hypertension.
    Kim GR; Cho SN; Kim HS; Yu SY; Choi SY; Ryu Y; Lin MQ; Jin L; Kee HJ; Jeong MH
    J Hypertens; 2016 Nov; 34(11):2206-19. PubMed ID: 27512969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gallic acid, a phenolic acid, hinders the progression of prostate cancer by inhibition of histone deacetylase 1 and 2 expression.
    Jang YG; Ko EB; Choi KC
    J Nutr Biochem; 2020 Oct; 84():108444. PubMed ID: 32615369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Class II histone deacetylases require P/Q-type Ca
    Urbano FJ; Bisagno V; Mahaffey S; Lee SH; Garcia-Rill E
    Sci Rep; 2018 Sep; 8(1):13156. PubMed ID: 30177751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide.
    Chang J; Varghese DS; Gillam MC; Peyton M; Modi B; Schiltz RL; Girard L; Martinez ED
    Br J Cancer; 2012 Jan; 106(1):116-25. PubMed ID: 22158273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein kinase D1 mediates class IIa histone deacetylase phosphorylation and nuclear extrusion in intestinal epithelial cells: role in mitogenic signaling.
    Sinnett-Smith J; Ni Y; Wang J; Ming M; Young SH; Rozengurt E
    Am J Physiol Cell Physiol; 2014 May; 306(10):C961-71. PubMed ID: 24647541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid.
    Zhao L; Chen CN; Hajji N; Oliver E; Cotroneo E; Wharton J; Wang D; Li M; McKinsey TA; Stenmark KR; Wilkins MR
    Circulation; 2012 Jul; 126(4):455-67. PubMed ID: 22711276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The inhibitory effects of class I histone deacetylases on hippocampal neuroinflammatory regulation in aging mice with postoperative cognitive dysfunction.
    Yang CX; Bao F; Zhong J; Zhang L; Deng LB; Sha Q; Jiang H
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10194-10202. PubMed ID: 33090427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors.
    De Vreese R; D'hooghe M
    Eur J Med Chem; 2017 Jul; 135():174-195. PubMed ID: 28453994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CaMKII exacerbates heart failure progression by activating class I HDACs.
    Zhang M; Yang X; Zimmerman RJ; Wang Q; Ross MA; Granger JM; Luczak ED; Bedja D; Jiang H; Feng N
    J Mol Cell Cardiol; 2020 Dec; 149():73-81. PubMed ID: 32971072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3,3'-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells.
    Beaver LM; Yu TW; Sokolowski EI; Williams DE; Dashwood RH; Ho E
    Toxicol Appl Pharmacol; 2012 Sep; 263(3):345-51. PubMed ID: 22800507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases.
    Cleophas MC; Crişan TO; Lemmers H; Toenhake-Dijkstra H; Fossati G; Jansen TL; Dinarello CA; Netea MG; Joosten LA
    Ann Rheum Dis; 2016 Mar; 75(3):593-600. PubMed ID: 25589513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Class II-Selective Histone Deacetylase Inhibitor on Neuromuscular Function and Disease Progression in SOD1-ALS Mice.
    Buonvicino D; Felici R; Ranieri G; Caramelli R; Lapucci A; Cavone L; Muzzi M; Di Pietro L; Bernardini C; Zwergel C; Valente S; Mai A; Chiarugi A
    Neuroscience; 2018 May; 379():228-238. PubMed ID: 29588251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral administration of the Class-IIa HDAC inhibitor MC1568 partially protects against nigrostriatal neurodegeneration in the striatal 6-OHDA rat model of Parkinson's disease.
    Mazzocchi M; Goulding SR; Morales-Prieto N; Foley T; Collins LM; Sullivan AM; O'Keeffe GW
    Brain Behav Immun; 2022 May; 102():151-160. PubMed ID: 35217173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Hydroxamic Acids Incorporating 1-((1H-1,2,3-Triazol-4-yl)methyl)- 3-substituted-2-oxoindolines: Synthesis, Biological Evaluation and SAR Analysis.
    Dung DTM; Huan NV; Cam DM; Hieu DC; Hai PT; Huong LT; Kim J; Choi JE; Kang JS; Han SB; Nam NH
    Med Chem; 2018; 14(8):831-850. PubMed ID: 29807520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.